-
Mix Sector Stocks: Theravance Inc. (NASDAQ:THRX), The Dow Chemical Company (NYSE:DOW), Ciber (NYSE:CBR), MGM Resorts International (NYSE:MGM), Raytheon Company (NYSE:RTN)
On Feb 19, Theravance Inc. (NASDAQ:THRX) reported a fourth-quarter 2014 loss of 14 cents per share, in line with the Zacks Consensus Estimate. The company had incurred a loss of 46 cents per share a year ago. However, the year-ago number represented the results of the combined company (royalty management and the biopharma division). On…
-
Mix Sector Stocks: Theravance Inc. (NASDAQ:THRX), Freeport-McMoRan Inc. (NYSE:FCX), Stryker Corporation (NYSE:SYK), Ford Motor Company (NYSE:F), Borderfree (NASDAQ:BRDR)
Theravance Inc. (NASDAQ:THRX) reported a fourth-quarter 2014 loss of 14 cents per share, in line with the Zacks Consensus Estimate. The company had incurred a loss of 46 cents per share a year ago. However, the year-ago number represented the results of the combined company (royalty management and the biopharma division). On Thursday shares of…
-
Mix Sector Stocks News: Petroleo Brasileiro Petrobras (NYSE:PBR), Theravance Inc. (NASDAQ:THRX), L-3 Communications (NYSE:LLL), TRW Automotive (NYSE:TRW), Atlantic Coast Financial (NASDAQ:ACFC)
Brazil’s state-run oil firm Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) plans to publish audited results for 2014 by the end of May, the company said on 12 February in a securities filing. On Thursday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) closed at $6.64. Company’s sales growth for last 5 years was 3.60% and…
-
Investors Should Watch: Theravance Inc. (NASDAQ:THRX), Microsoft Corporation (NASDAQ:MSFT), Frisch’s Restaurants (NYSEMKT:FRS), Republic Airways Holdings Inc. (NASDAQ:RJET), Portugal Telecom (NYSE:PT)
Theravance, Inc. (NASDAQ:THRX) announced that on March 19, 2015, the U.S. Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee will discuss the supplemental New Drug Application (NDA) 204275-S001, for fluticasone furoate and vilanterol dry powder for inhalation (with the brand name of BREO® ELLIPTA®), sponsored by Glaxo…
-
Why Investor’s Are Watching: FMSA Holdings Inc (NYSE:FMSA), Rite Aid Corporation (NYSE:RAD), Peabody Energy Corp. (NYSE:BTU), Theravance Inc. (NASDAQ:THRX), Gildan Activewear (NYSE:GIL)
FMSA Holdings (NASDAQ:FMSA) has received a consensus recommendation of “Hold” from the ten brokerages that are currently covering the stock, Analyst Ratings Network.com reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and five have issued a buy recommendation on the company. On Friday shares of…
-
Investors Are Gambling: Tesla Motors Inc (NASDAQ:TSLA), Theravance Inc. (NASDAQ:THRX), UMB Financial Corporation (NASDAQ:UMBF), Arena Pharmaceuticals (NASDAQ:ARNA), AstraZeneca PLC (NYSE:AZN)
Tesla Motors Inc (NASDAQ:TSLA) have revealed its newest 2015 Tesla S P85D model at the recent 2015 Detroit Motor Show. Company’s models S marked for the first time appearing on auto show with its latest all-wheel-drive and twin-motor version. However, P85D as the performance oriented model features front axle powered with extra drive engine combining…
-
Traders Buzz: BGC Partners (NASDAQ:BGCP), International Business Machines Corporation (NYSE:IBM), Eaton Vance Duration Income Fund (NYSEMKT:EVV), Theravance (NASDAQ:THRX), Sonic Foundry (NASDAQ:SOFO)
BGC Partners, Inc. (NASDAQ:BGCP), announced Monday that it has launched BGC Trader for Yen Interest Rate Swaps or IRS. BGC noted that it is the first interdealer broker to launch a fully electronic platform for the Yen IRS market. This new market offering utilizes BGC Trader, BGC’s proprietary multi-asset, integrated voice and electronic price execution…
-
Biotech Gainers: Genetic Technologies Limited (NASDAQ:GENE), Esperion Therapeutics (NASDAQ:ESPR), Theravance Inc. (NASDAQ:THRX), RXi Pharmaceuticals Corporation (NASDAQ:RXII), Recro Pharma (NASDAQ:REPH)
Genetic Technologies Limited (NASDAQ:GENE) on 29 January announced that up to 6 new breast diagnosis/treatment centers are expected to begin offering BREVAGenplus? to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growing number of additional new breast and imaging center customers expected to follow later in calendar…
-
Why Traders Are Watching: Xenon Pharmaceuticals Inc. (NASDAQ:XENE), Theravance Inc. (NASDAQ:THRX), QLogic Corp. (NASDAQ:QLGC), Apricus Biosciences (NASDAQ:APRI), ATRION Corp. (NASDAQ:ATRI)
Canaccord Genuity reaffirmed their buy rating on shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) in a research note issued to investors on Tuesday. The firm currently has a $30.00 price target on the stock. On Tuesday shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) closed at $15.81. Company’s EPS growth for next 5 years is recorded as 10.00%.…
-
Biotech Stocks New Lows: Histogenics Corporation (NASDAQ:HSGX), Cleveland BioLabs (NASDAQ:CBLI), Theravance Inc. (NASDAQ:THRX), Celsion Corp. (NASDAQ:CLSN), VIVUS Inc. (NASDAQ:VVUS)
BTIG Research initiated coverage on shares of Histogenics Corp (NASDAQ:HSGX) in a research report released on Friday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $13.00 price objective on the stock. On Wednesday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $7.11. Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced that at a special meeting…